Drugs / FSH
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00696878 Background | Sep 2006 → Feb 2009 | — | Organon and Co | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FSH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00696878 ↗ |
| Modality | Protein / enzyme biologic | “daily recombinant follicle stimulating hormone (rFSH) from day 8 onwards.” PMID 26991902 ↗ May 2016 |
| Route | Subcutaneous | “FSH administerd subcutaneously at a dose not to exceed 225 IU/day.” NCT00696878 ↗ |